Anne Johanne Søgaard1, Haakon E Meyer2, Nina Emaus3, Guri Grimnes4, Clara Gram Gjesdal5, Siri Forsmo6, Berit Schei7, Grethe S Tell8. 1. Norwegian Institute of Public Health, Oslo, Norway anne.johanne.sogaard@fhi.no. 2. Norwegian Institute of Public Health, Oslo, Norway Institute of Health and Society, University of Oslo, Oslo, Norway. 3. Department of Health and Care Sciences, UiT The Arctic University of Norway, Tromsø, Norway. 4. Department of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway Division of Internal Medicine, University Hospital of North Norway, Tromsø, Tromsø, Norway. 5. Department of Clinical Science, University of Bergen, Bergen Department of Rheumatology, Haukeland University Hospital, Bergen, Norway. 6. Department of Public Health and General Practice, Norwegian University of Science and Technology, Trondheim, Norway. 7. Department of Public Health and General Practice, Norwegian University of Science and Technology, Trondheim, Norway Department of Obstetrics and Gynecology, St. Olavs Hospital, Trondheim. 8. Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.
Abstract
AIMS: This paper describes the history, purpose, data collection and contributions in the research collaboration Norwegian Osteoporosis Epidemiologic Studies (NOREPOS). METHODS: NOREPOS encompasses almost 85,000 bone mineral density measurements within Cohort of Norway and data on almost 140,000 hip fractures in Norway 1994-2008. Included are anthropometric measurements, blood pressure, lipids and glucose, and 50 standard questions on sociodemographic factors, diseases and risk factors. Blood samples/DNA are stored. The main research question posed in NOREPOS is why hip fracture rates in Norway are the highest in the world. Data on hip fractures 2009-2013 will be added in 2014. RESULTS: Main findings include: Every hour a Norwegian suffers a hip fracture; hip fracture incidence rates declined after 1999; only 16% of patients used anti-osteoporosis drugs 1 year after hip fracture; 25% of patients died within 1 year after the fracture; 12% suffered a new hip fracture within 10 years; rural dwellers had lower hip and forearm fracture incidence than city dwellers; magnesium in tap water may be protective whereas bacterial contamination, cadmium and lead may be harmful to bone health; low serum vitamin D and E levels were associated with higher hip fracture risk; vitamin A was not associated with fracture risk; and abdominal obesity increased the risk of hip fracture when BMI was accounted for. CONCLUSIONS: NOREPOS encompasses a unique source of information for aetiological research, genetic studies as well as for biomarkers of osteoporosis and fractures. Because of the increasing number of elderly people in Europe, hip fractures will continue to pose an international public health and health care challenge.
AIMS: This paper describes the history, purpose, data collection and contributions in the research collaboration Norwegian Osteoporosis Epidemiologic Studies (NOREPOS). METHODS: NOREPOS encompasses almost 85,000 bone mineral density measurements within Cohort of Norway and data on almost 140,000 hip fractures in Norway 1994-2008. Included are anthropometric measurements, blood pressure, lipids and glucose, and 50 standard questions on sociodemographic factors, diseases and risk factors. Blood samples/DNA are stored. The main research question posed in NOREPOS is why hip fracture rates in Norway are the highest in the world. Data on hip fractures 2009-2013 will be added in 2014. RESULTS: Main findings include: Every hour a Norwegian suffers a hip fracture; hip fracture incidence rates declined after 1999; only 16% of patients used anti-osteoporosis drugs 1 year after hip fracture; 25% of patients died within 1 year after the fracture; 12% suffered a new hip fracture within 10 years; rural dwellers had lower hip and forearm fracture incidence than city dwellers; magnesium in tap water may be protective whereas bacterial contamination, cadmium and lead may be harmful to bone health; low serum vitamin D and E levels were associated with higher hip fracture risk; vitamin A was not associated with fracture risk; and abdominal obesity increased the risk of hip fracture when BMI was accounted for. CONCLUSIONS: NOREPOS encompasses a unique source of information for aetiological research, genetic studies as well as for biomarkers of osteoporosis and fractures. Because of the increasing number of elderly people in Europe, hip fractures will continue to pose an international public health and health care challenge.
Authors: P Sáez-López; F Brañas; N Sánchez-Hernández; N Alonso-García; J I González-Montalvo Journal: Osteoporos Int Date: 2016-11-21 Impact factor: 4.507
Authors: T E Finnes; C M Lofthus; H E Meyer; A J Søgaard; G S Tell; E M Apalset; C Gjesdal; G Grimnes; B Schei; R Blomhoff; S O Samuelsen; K Holvik Journal: Osteoporos Int Date: 2015-12-02 Impact factor: 4.507
Authors: Siri M Solbakken; Jeanette H Magnus; Haakon E Meyer; Cecilie Dahl; Hein Stigum; Anne J Søgaard; Kristin Holvik; Grethe S Tell; Nina Emaus; Siri Forsmo; Clara G Gjesdal; Berit Schei; Peter Vestergaard; Tone K Omsland Journal: JBMR Plus Date: 2019-10-21